About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
5th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner
5th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner Center for the Evaluation of Value and Risk in Health (CEVR) at T...
New CEVR publication: Cost-effectiveness thresholds used by study authors, 1990-2021
Journal: Journal of the American Medical Association Citation: Neumann PJ, Kim DD. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JA...
CEVR Remembers Philanthropist Gordon Moore
CEVR Remembers Philanthropist Gordon Moore The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center mourns the passin...
View All News Items
Events
Health Policy Seminar with Victoria Fan, ScD
Seminar with Brian D Smith, BSc, DipM PhD FRSA
Health Policy Seminar with Hadley Stevens Smith, PhD, MPSA
View All Events
Publications
Journal of Managed Care and Specialty Pharmacy
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
Journal of the American Medical Association
Cost-effectiveness thresholds used by study authors, 1990-2021
Value in Health
Developing Criteria for Health Economic Quality Evaluation Tool
BioDrugs
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans
Health Policy OPEN
The impact of external reference pricing on pharmaceutical costs and market dynamics
Journal of Managed Care + Specialty Pharmacy
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
STAT News First Opinion
The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy
Journal of Managed Care + Specialty Pharmacy
Commercial health plans use of patient subgroup restrictions: An analysis of orphan and FDA-expedited programs
Alzheimer's & Dementia
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease
View All Publications